Dovitinib Combined With Bortezomib and Dexamethasone for Relapsed/Refractory Multiple Myeloma

Stopped The target drug, dovitinib, failed as a single agent in prior studies in patients with heavily treated multiple myeloma.

Conditions

• Multiple Myeloma

Interventions

• DRUG: Dovitinib
• DRUG: Bortezomib
• DRUG: Dexamethasone

Sponsor

University of Florida

Collaborators

• [object Object]